A Review of Public Policy Issues in Promoting the Development and Commercialization of Pharmacogenomic Applications: Challenges and Implications

Author： Garrison Louis   Carlson Rick   Carlson Josh   Kuszler Patricia   Meckley Lisa   Veenstra David  

Publisher： Informa Healthcare

ISSN： 0360-2532

Source： Drug Metabolism Reviews, Vol.40, Iss.2, 2008-04, pp. : 377-401

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenomic data sample collection and storage: ethical issues and policy approaches

By Joly Yann   Knoppers Bartha M  

Pharmacogenomics, Vol. 7, Iss. 2, 2006-03 ,pp. : 219-226

Future Medicine

Access to resources Recommend Favorite

Common variations in platelet glycoproteins: pharmacogenomic implications

By Quinn Martin J   Topol Eric J  

Pharmacogenomics, Vol. 2, Iss. 4, 2001-11 ,pp. : 341-352

Future Medicine

Access to resources Recommend Favorite

Systematic Review of Public Education and Policy for Stroke Prevention

By  

Current Drug Targets, Vol. 8, Iss. 7, 2007-07 ,pp. : 874-879

Bentham Science Publishers

Access to resources Recommend Favorite

Ethical issues and the commercialization of embryo culture media

By Biggers John D  

Reproductive BioMedicine Online, Vol. 1, Iss. 3, 2000-12 ,pp. : 74-76

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

The Use of Psychotropic Agents in Preschool Children: Issues in Practice, Research and Public Policy

By  

Child and Adolescent Psychopharmacology News, Vol. 14, Iss. 4, 2009-08 ,pp. : 1-5

Guilford Publications Inc

Access to resources Recommend Favorite